• Interim US guidance for risk assessment and public health management of persons with potential 2019 novel coronavirus (2019-nCoV) exposure in travel-associated or community settings Cite CITE Title : Interim US guidance for risk assessment and public health management of persons with potential 2019 novel coronavirus (2019-nCoV) exposure in travel-associated or community settings Corporate Authors(s) : National Center for Immunization and Respiratory Diseases (U.S.). Division of Viral Diseases. Published Date : February 3, 2020 Series : 2019 novel coronavirus URL : https://stacks.cdc.gov/view/cdc/84776 National Center for Immunization and Respiratory Diseases (U.S.). Division of Viral Diseases. (2020). Interim US guidance for risk assessment and public health management of persons with potential 2019 novel coronavirus (2019-nCoV) exposure in travel-associated or community settings. National Center for Immunization and Respiratory Diseases (U.S.). Division of Viral Diseases. "Interim US guidance for risk assessment and public health management of persons with potential 2019 novel coronavirus (2019-nCoV) exposure in travel-associated or community settings" (2020) National Center for Immunization and Respiratory Diseases (U.S.). Division of Viral Diseases. "Interim US guidance for risk assessment and public health management of persons with potential 2019 novel coronavirus (2019-nCoV) exposure in travel-associated or community settings" , 2020 Export RIS Citation Information. Copy Copied Save Generic APA MLA Chicago RIS [PDF - 691.22 KB] Corporate Authors: National Center for Immunization and Respiratory Diseases (U.S.). Division of Viral Diseases. February 3, 2020 | 2019 novel coronavirus Description: This interim guidance is effective as of February 3, 2020, and does not apply retrospectively to people who have been in China during the previous 14 ... File Type: [PDF - 691.22 KB] File Type: [PDF - 691.22 KB] 2019-nCoV situation summary 2019 novel coronavirus (2019-nCoV) in the U.S : updated February 3, 2020 Cite CITE Title : 2019-nCoV situation summary 2019 novel coronavirus (2019-nCoV) in the U.S : updated February 3, 2020 Corporate Authors(s) : Centers for Disease Control and Prevention (U.S.) Published Date : February 3, 2020 Series : 2019 novel coronavirus URL : https://stacks.cdc.gov/view/cdc/84778 Centers for Disease Control and Prevention (U.S.) (2020). 2019-nCoV situation summary 2019 novel coronavirus (2019-nCoV) in the U.S : updated February 3, 2020. Centers for Disease Control and Prevention (U.S.) "2019-nCoV situation summary 2019 novel coronavirus (2019-nCoV) in the U.S : updated February 3, 2020" (2020) Centers for Disease Control and Prevention (U.S.) "2019-nCoV situation summary 2019 novel coronavirus (2019-nCoV) in the U.S : updated February 3, 2020" , 2020 Export RIS Citation Information. Copy Copied Save Generic APA MLA Chicago RIS [PDF - 258.21 KB] Corporate Authors: Centers for Disease Control and Prevention (U.S.) February 3, 2020 | 2019 novel coronavirus Description: This is an emerging, rapidly evolving situation and CDC will provide updated information as it becomes available, in addition to updated guidance.Upda... File Type: [PDF - 258.21 KB] File Type: [PDF - 258.21 KB] 2019 novel coronavirus frequently asked questions and answers Cite CITE Title : 2019 novel coronavirus frequently asked questions and answers Corporate Authors(s) : National Center for Immunization and Respiratory Diseases (U.S.). Division of Viral Diseases. Published Date : February 3, 2020 Series : 2019 novel coronavirus URL : https://stacks.cdc.gov/view/cdc/84775 National Center for Immunization and Respiratory Diseases (U.S.). Division of Viral Diseases. (2020). 2019 novel coronavirus frequently asked questions and answers. National Center for Immunization and Respiratory Diseases (U.S.). Division of Viral Diseases. "2019 novel coronavirus frequently asked questions and answers" (2020) National Center for Immunization and Respiratory Diseases (U.S.). Division of Viral Diseases. "2019 novel coronavirus frequently asked questions and answers" , 2020 Export RIS Citation Information. Copy Copied Save Generic APA MLA Chicago RIS [PDF - 73.52 KB] Corporate Authors: National Center for Immunization and Respiratory Diseases (U.S.). Division of Viral Diseases. February 3, 2020 | 2019 novel coronavirus No Description File Type: [PDF - 73.52 KB] File Type: [PDF - 73.52 KB] 2019 novel coronavirus cases in the U.S. : updated February 3, 2020 Cite CITE Title : 2019 novel coronavirus cases in the U.S. : updated February 3, 2020 Corporate Authors(s) : Centers for Disease Control and Prevention (U.S.) Published Date : February 3, 2020 Series : 2019 novel coronavirus URL : https://stacks.cdc.gov/view/cdc/84777 Centers for Disease Control and Prevention (U.S.) (2020). 2019 novel coronavirus cases in the U.S. : updated February 3, 2020. Centers for Disease Control and Prevention (U.S.) "2019 novel coronavirus cases in the U.S. : updated February 3, 2020" (2020) Centers for Disease Control and Prevention (U.S.) "2019 novel coronavirus cases in the U.S. : updated February 3, 2020" , 2020 Export RIS Citation Information. Copy Copied Save Generic APA MLA Chicago RIS [PDF - 425.71 KB] Corporate Authors: Centers for Disease Control and Prevention (U.S.) February 3, 2020 | 2019 novel coronavirus Description: CDC is closely monitoring an outbreak of respiratory illness caused by a novel (new) coronavirus named 2019-nCoV. The outbreak first started in Wuhan,... File Type: [PDF - 425.71 KB] File Type: [PDF - 425.71 KB] 2019 novel coronavirus : prevention & treatment Cite CITE Title : 2019 novel coronavirus : prevention & treatment Corporate Authors(s) : National Center for Immunization and Respiratory Diseases (U.S.). Division of Viral Diseases. Published Date : February 3, 2020 Series : 2019 novel coronavirus URL : https://stacks.cdc.gov/view/cdc/84771 National Center for Immunization and Respiratory Diseases (U.S.). Division of Viral Diseases. (2020). 2019 novel coronavirus : prevention & treatment. National Center for Immunization and Respiratory Diseases (U.S.). Division of Viral Diseases. "2019 novel coronavirus : prevention & treatment" (2020) National Center for Immunization and Respiratory Diseases (U.S.). Division of Viral Diseases. "2019 novel coronavirus : prevention & treatment" , 2020 Export RIS Citation Information. Copy Copied Save Generic APA MLA Chicago RIS [PDF - 45.70 KB] Corporate Authors: National Center for Immunization and Respiratory Diseases (U.S.). Division of Viral Diseases. February 3, 2020 | 2019 novel coronavirus No Description File Type: [PDF - 45.70 KB] File Type: [PDF - 45.70 KB]

More +